Founded in July 2023 and based in Thailand’s leading academic research ecosystem, SKAI MED is a health-technology innovator dedicated to advancing non-invasive vascular and physiological screening through the integration of sensor engineering, artificial intelligence, and clinical science.
Our work is driven by a simple but urgent belief:
early detection, continuous monitoring, and data-driven clinical insights should be accessible, affordable, and scalable — not limited by cost, complexity, or specialist availability.

Cardiovascular disease, stroke, hypertension, and chronic kidney disease remain among the world’s most serious health challenges — not due to a lack of treatment options, but because disease risk is often detected too late.
At SKAI MED, our mission is to shift healthcare from reactive treatment toward early identification, prevention, and proactive care. We do this by creating technology platforms that enable:
- Rapid, non-invasive screening
- Continuous physiological monitoring
- Data-driven clinical decision support
- Scalable deployment across primary care and specialty settings
Our goal is to empower clinicians, healthcare providers, and individuals with tools that make preventive healthcare practical, reliable, and widely accessible.
Our operations are structured around three complementary pillars, allowing us to deliver both technological innovation and clinical value at scale.
1. Technology Licensing
We develop proprietary sensing platforms, signal analytics engines, and clinical software systems that can be licensed to hospitals, healthcare networks, and industry partners. This enables rapid adoption while maintaining strong intellectual property boundaries, supported by implementation guidance, continuous software updates, and long-term system expansion.
2. Innovation & Technology Consulting
We collaborate with healthcare organizations, research institutions, and industry partners to translate clinical and strategic goals into executable technical solutions. Our consulting approach emphasizes practical system design, measurable outcomes, and deployable architectures, ensuring innovation leads to real-world impact rather than abstract strategy.
3. Clinical Trial & Validation Services
SKAI MED provides end-to-end support for clinical studies, focusing on physiological measurement, digital biomarkers, and screening-to-monitoring pathways. Through close collaboration with clinicians and research partners, we design protocols, manage data workflows, and convert biosignals into clinically meaningful endpoints — strengthening regulatory readiness and clinical adoption.
